R7 (effective 09/01/2011): LCD revised to replace the list of ICD-9 Codes that Support Medical Necessity with a link to the NCD for Lipid Testing, where ICD-9 Codes are maintained. No comment or notice periods required and none given.

R5 (effective 09/01/2011): ICD-9 code 275.3 was added to the list of payable ICD-9 codes for Parathormone. No comment and notice periods required and none given.

R3 (effective 09/01/2011): LCD revised to replace the list of ICD-9 Codes that Support Medical Necessity with a link to the NCD for Partial Thromboplastin Time, where ICD-9 Codes are maintained. No comment or notice periods required and none given.

R4 (effective 09/01/2011): LCD revised to replace the list of ICD-9 Codes that Support Medical Necessity with a link to the NCD for Prothrombin Time, where ICD-9 Codes are maintained. No comment or notice periods required and none given.

Article published September 2011: The carrier or Part B MAC coding guideline listed below was revised to include an assisted living facility (13), group home (14), temporary lodging (16) and custodial care facility (33) as payable places of service for CPT codes 92526 and 92610.

For CPT codes 92526 and 92610: Office (11), home (12), assisted living facility (13), group home (14), temporary lodging (16), inpatient hospital (21), outpatient hospital (22), emergency room (23), ambulatory surgical center (24), skilled nursing facility (31) nursing facility (32), custodial care facility (33) and independent clinic (49).

Article published September 2011: The following coding guideline was inadvertently included with the revision published on April 1, 2010 and has been removed on the basis that CPT code 86780 is not a CLIA waived test:

For dates of service on or after 01/01/2010, modifier QW should be appended to CPT code 86780 to indicate a CLIA waived test.

Minor template changes were made to reflect current template language.

R16 (effective 08/11/2011): The article for Sipuleucel-T (Provenge®) (A50060) has been removed effective 08/04/2011. Please refer to CMS Publication 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 2: 110.22 Autologous Cellular Immunotherapy Treatment (Effective June 30, 2011). No comment and notice period required and none given.

Article retired 08/04/2011: This article is being retired effective for dates of service on or after 06/30/2011. Please refer to CMS Publication 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 2: 110.22 Autologous Cellular Immunotherapy Treatment (Effective June 30, 2011).